Pfizer (PFE) insider trading and SEC filings
PFIZER INC · NYSE · Pharmaceutical Preparations
Company facts
What Pfizer tells the SEC about itself on the same registration record these filings come from.
- Industry (SIC) — Pharmaceutical Preparations
- Exchange — NYSE
- Filer category — Large accelerated filer
- Fiscal year end — December 31
- State of incorporation — Delaware
- Former names — PFIZER INC (1994-2026)
PFE insider transactions
Officers, directors and 10% owners must tell the SEC when they buy or sell Pfizer stock, within two business days. These are the most recent, straight from EDGAR.
I read the 8 insider filings below, filed between Sep 16 and Oct 1, 2026, all on Form 4. Each one is about Pfizer stock and links to the original on EDGAR. They name 7 insiders: 6 directors and 1 officer. Pfizer's SEC record shows its latest 10-K filed Feb 26, 2026, its latest 10-Q Aug 4, 2026, and its latest 8-K Aug 4, 2026.
| Form | Filed | Insider | Transaction | Price | Trade date | Shares held after | Ownership | |
|---|---|---|---|---|---|---|---|---|
| 4 | 2026-10-01 | ALBERT BOURLA — Chairman & CEO | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | Buckley Mortimer J — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | Joseph Echevarria — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | SHANTANU NARAYEN — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | James Quincey — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | SMITH JAMES C — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-29 | Cyrus Taraporevala — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-16 | ALBERT BOURLA — Chairman & CEO | not itemised — see the filing | — | — | — | — | Filing |
Transaction wording follows the code on the filing itself — what each Form 4 code means. An option exercise or a tax withholding is not a market decision, and is not shown as one.
- Form 4 — An insider bought or sold company stock
Get PFE's filings, read.
Other recent Pfizer filings
| Form | Filed | Document |
|---|---|---|
| 10-Q | 2026-08-04 | 10-Q |
| 8-K | 2026-08-04 | 8-K |
| 8-K | 2026-06-18 | 8-K |
| 8-K | 2026-06-18 | 8-K |
| 10-Q | 2026-05-05 | 10-Q |
| 8-K | 2026-05-05 | 8-K |
| 8-K | 2026-04-27 | 8-K |
| 10-K | 2026-02-26 | 10-K |
Reading these accurately
A Form 4 records what happened, precisely and on the record — it has no field for why. A sale can be scheduled months in advance under a Rule 10b5-1 plan, and vesting and option exercises appear alongside open-market decisions. The fuller version is in what insider buying and selling actually signals; to look up any other company, use the insider filing tracker.
Insider filings for other companies
Companies filing in the same sector, and other names Pip tracks.